The vaccine speech given by Meghan Markle and Prince Harry was debunked: ‘Doesn’t reflect reality.’
Columnist Ross Clarke discredited MEGHAN MARKLE and Prince Harry’s New York speech on vaccination equity, and his research was then highlighted on a royal podcast.
Harry and Meghan made a series of public engagements in New York two weeks ago, coinciding with the United Nations General Assembly and President Joe Biden’s coronavirus summit.
The couple visited with politicians such as New York Mayor Bill de Blasio and US Ambassador to the United Nations Linda Thomas-Greenfield, as well as paying a visit to the 9/11 Memorial and Museum, which was only a few weeks after the tragedy’s twentieth anniversary. The Sussexes went to a school in Harlem the next day, where Meghan read her new children’s book The Bench to a class to promote literacy.
Harry and Meghan also attended the Global Citizen Live concert in Central Park, a 24-hour event that aimed to promote equal access to the coronavirus vaccine.
The pair grabbed the platform to advocate for vaccination fairness and to ask pharmaceutical corporations to relinquish their intellectual property rights to the COVID-19 vaccine.
“We’re fighting more than just the virus,” Harry explained.
“This is a war of misinformation, bureaucracy, lack of transparency, and lack of access, and above all, it is a human rights catastrophe,” says the author.
“Many countries are ready to develop vaccines at home, but they are unable to do so because ultra-wealthy pharmaceutical countries refuse to share the recipes with them,” he continued.
“These countries have the resources, expertise, and labor force to begin manufacturing. They’re only waiting for the intellectual property rights to the vaccine to be waived.” Mr Clark, writing in The Spectator, refuted their accusations that rich countries are hoarding vaccines and pharmaceutical companies are benefitting unfairly from the pandemic.
He said that AstraZeneca had made their vaccine available at cost and licensed production to the Serum Institute in India in order to provide vaccinations to low and middle income countries at a lower cost.
While some manufacturers have refused to transfer rights, Mr Clark pointed out that wealthy countries have contributed 300 million doses of the coronavirus vaccine to 142 countries, with another 1.3 billion due by the end of the year.
In this sense, he suggested that, while waiving patents may have been cheaper for taxpayers, it “made little odds” for the jab recipients.
“Brinkwire Summary News” is the title of the article.